[1]
J. L. Sandoval-Ramirez, J. A. Mata-Marín, G. Huerta García, and J. E. Gaytán-Martínez, “Responses to peginterferon alfa-2a vs alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C”, J Infect Dev Ctries, vol. 9, no. 03, pp. 267–273, Mar. 2015.